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Abstract Ϯϭ
Semi-Volatile Organic Compounds (SVOCs) are commonly present in dwellings and several are ϮϮ
suspected of having effects on male reproductive function mediated by an endocrine disruption Ϯϯ
mode of action. To improve knowledge of the health impact of these compounds, cumulative Ϯϰ
toxicity indicators are needed. This work derives Benchmark Doses (BMD) and Relative Potency Ϯϱ
Factors (RPF) for SVOCs acting on the male reproductive system through the same mode of Ϯϲ
action. Ϯϳ
We included SVOCs fulfilling the following conditions: detection frequency (>10%) in French Ϯϴ
dwellings, availability of data on the mechanism / mode of action for male reproductive toxicity, Ϯϵ
and availability of comparable dose-response relationships. ϯϬ
Of 58 SVOCs selected, 18 induce a decrease in serum testosterone levels. Six have sufficient and ϯϭ
comparable data to derive BMDs based on 10 or 50% of the response. The SVOCs inducing the ϯϮ
largest decrease in serum testosterone concentration are: for 10%, bisphenol A (BMD10= 7.72E-ϯϯ
07 mg/kg bw/d; RPF10= 7033679); for 50%, benzo[a]pyrene (BMD50= 0.030 mg/kg bw/d; ϯϰ
RPF50= 1630), and the one inducing the smallest one is benzyl butyl phthalate (RPF10 and RPF50= ϯϱ
0.095).  ϯϲ
This approach encompasses contaminants from diverse chemical families acting through similar ϯϳ
modes of action, and makes possible a cumulative risk assessment in indoor environments. The ϯϴ
main limitation remains the lack of comparable toxicological data.  ϯϵ
ϰϬ
Keywords: semi-volatile organic compounds; benchmark doses; cumulative risk assessment; ϰϭ
reproduction; mixture; toxicity  ϰϮ
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1. Introduction ϰϯ
Semi-volatile organic compounds (SVOCs) include numerous molecules belonging to different ϰϰ
chemical families such as phthalates, polycyclic aromatic hydrocarbons (PAHs), musks, ϰϱ
polybromodiphenyl ethers (PBDEs), polychlorobiphenyls (PCBs) or pyrethroid insecticides ϰϲ
(Weschler and Nazaroff, 2008). They can be defined as “organic compounds with vapour ϰϳ
pressures between 10-14 and 10-4atm (10-9 to 10Pa)” and whose boiling point is between (240 to ϰϴ
260°C) and (380 to 400°C) (NF ISO 16000-6, 2006) (Weschler and Nazaroff, 2008). They are ϰϵ
used for their technical properties in a large variety of building materials and consumer products ϱϬ
(plastics, paints, cleaning agents, biocides, furniture, etc.), and are also emitted by combustion ϱϭ
processes. Due to their widespread usage and chemical properties, their presence is ubiquitous in ϱϮ
indoor environments, in both settled dust and air (gaseous phase and particulate matter) (Mercier ϱϯ
et al., 2011, Blanchard et al., 2014). Many SVOCs are suspected of having endocrine disruption ϱϰ
mechanisms, leading to potential effects on male reproduction. Among them, phthalates are ϱϱ
considered anti-androgenic compounds, responsible for an inhibition of steroidogenesis ϱϲ
(Svechnikov et al., 2008), leading to a decrease in anogenital distance and nipple retention, as ϱϳ
well as an increase in the incidence of hypospadias and cryptorchidism in rats exposed during the ϱϴ
prenatal period (Gray et al., 2000). A significant decrease in serum testosterone levels was ϱϵ
observed in rodents following oral exposure to BDE-99 (Alonso et al., 2010), benzo[a]pyrene ϲϬ
(B(a)P) (Liang et al., 2012) or cypermethrin (Jin et al., 2011). In addition, in rats, cypermethrin ϲϭ
decreases expression of the androgen receptor after 2 weeks of oral exposure (Liu et al., 2010). ϲϮ
The effects of bisphenol A (BPA) on testosterone synthesis may be controversial, yet further ϲϯ
studies have shown BPA to have negative effects on this hormone. For example, Salian et al. ϲϰ
observed a significant decrease in testosterone concentration in rats pre and postnatally exposed ϲϱ
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(Salian et al., 2009). Della Seta et al. observed the same phenomenon following exposure from ϲϲ
postnatal day 23 to postnatal day 30 (Della Seta et al., 2006). ϲϳ
In humans, authors have demonstrated in vitro endocrine disruption properties for a mixture ϲϴ
including phthalates and BPA (Christen et al., 2012) and also for DEHP and MEHP alone ϲϵ
(Desdoits-Lethimonier et al., 2012). ϳϬ
SVOC endocrine properties have also been suggested through epidemiological studies. Hauser et ϳϭ
al. observed a dose-dependent negative association between monobutyl phthalate (MBP) and ϳϮ
sperm concentration and motility in a population of 463 male partners of subfertile couples ϳϯ
(Hauser et al., 2006). Others groups found similar results between MBP and MEP exposure, and ϳϰ
sperm mobility / concentration (Duty et al., 2003); metabolites of long-chained phthalates ϳϱ
(MEHP and MiNP) and testosterone production (Meeker et al., 2009); MBP and MEHP and ϳϲ
serum-free testosterone (Pan et al., 2006); flame retardant (PBDEs) and serum testosterone ϳϳ
concentration (Johnson et al., 2013), and sperm quality (Abdelouahab et al., 2011); BPA and ϳϴ
male sexual function (Li et al., 2010) or semen quality (Meeker et al., 2010). Alteration of protein ϳϵ
expression can represent important key events in a modes of action (MOAs), or molecular ϴϬ
initiating event in an adverse outcome pathways (AOPs), leading to an adverse outcome ϴϭ
(Chepelev et al., 2014). Sonich-Mullin defined MOA as a “biologically plausible series of key ϴϮ
events leading to an effect” (Sonich-Mullin et al., 2001). An AOP is conceptually similar to a ϴϯ
MOA but includes an initial point of interaction of a chemical with biological systems (Meek et ϴϰ
al., 2014). It is difficult to know and understand the entire MOA/AOP leading to reprotoxic ϴϱ
effects but with a view of the preview information, we can consider the alteration of protein ϴϲ
synthesis (e.g. testosterone) as a potential early key event leading to reprotoxic effects. ϴϳ
As underline by Chepelev, protein expression analysis could contributed in health risk assessment ϴϴ
(Chepelev et al., 2014). Thus, Cumulative Risk Assessment (CRA) could be used to address this ϴϵ
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concern, with a view to assessing whether environmental exposure levels to SVOCs pose a risk, ϵϬ
and to help set maximum exposure levels not to be exceeded in indoor environments. A variety of ϵϭ
CRA methodologies have already been suggested and recently reviewed (Fournier et al., 2014a). ϵϮ
Some of them, including toxic equivalency factors (TEF) and relative potency factors (RPF) ϵϯ
approaches have been used to identify relative toxic potencies on various chemical mixtures. This ϵϰ
is the case of dioxins and PCBs (Ahlborg et al., 1994); polychlorinated dibenzo-p-dioxins ϵϱ
(PCDD) (OME, 1985); pesticides (Jensen et al., 2013) and PAHs (Nisbet and LaGoy, 1992). ϵϲ
These approaches are based on the dose additivity assumption (Loewe and Muischnek, 1926) as ϵϳ
suggested by the US EPA (US EPA, 2002) and consider a common mode of action (US EPA, ϵϴ
2000). This assumption does not take into account the possibility of toxicological interactions ϵϵ
that are not, or are rarely expected with exposure to low doses of contaminants(ATSDR, 2004). ϭϬϬ
These approaches were extended to other SVOCs including phthalates, fungicides or pyrethroids ϭϬϭ
(Christiansen et al., 2012; Hannas et al., 2011; Kortenkamp and Faust, 2010; Wolansky et al., ϭϬϮ
2005), but none of them is based on real exposure, where a variety of chemical families are ϭϬϯ
encountered. ϭϬϰ
The aim of this work is to estimate RPFs based on comparable benchmark doses (BMDs) for ϭϬϱ
multiple reprotoxic contaminants present in indoor environments. The choice of the BMD rather ϭϬϲ
than the NOAEL/LOAEL as an indicator of the toxicity was decided to reduce uncertainty due to ϭϬϳ
data heterogeneity (EFSA, 2006). ϭϬϴ
ϭϬϵ
2. Material and Method ϭϭϬ
2.1. Selection and grouping of indoor SVOCs ϭϭϭ
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The selection of chemicals was made on the basis of different measurement campaigns in French ϭϭϮ
dwellings (Mandin et al., 2014a, 2014b ; Blanchard et al., 2014), where 66 compounds selected ϭϭϯ
from a previous ranking (Bonvallot et al., 2010) were simultaneously analysed in a range of ϭϭϰ
environmental media (air, gas phase or particle matter, settled dust) using a multi-residue method ϭϭϱ
(Mercier et al., 2012, 2014). SVOCs were selected where they were detected in more than 10% of ϭϭϲ
the investigated houses (from 30 to 285 according to the campaign). ϭϭϳ
SVOC grouping was based on our previously described approach (Fournier et al., 2014b). ϭϭϴ
Briefly, hazard identification, for each chemical, was performed by means of a literature review ϭϭϵ
on its reprotoxic effects. To be eligible, the toxicological studies (in vivo or in vitro) should ϭϮϬ
describe the target organs or cells, or the mechanisms of action on the male reproductive system ϭϮϭ
or organs. SVOCs were then grouped by common effect, mode and/or mechanism of action. ϭϮϮ
According to the data, and in order to estimate RPFs, we chose to select the group including the ϭϮϯ
largest number of SVOCs, and for which a biological pathway is known. ϭϮϰ
2.2. Benchmark doses derivation ϭϮϱ
The BMD is defined as a dose (or concentration) producing a predetermined change in the ϭϮϲ
response rate of an effect (known as the benchmark response or BMR) compared with the ϭϮϳ
background response rate of this effect (US EPA, glossary: ϭϮϴ
http://www.epa.gov/risk_assessment/glossary.htm). It provides a quantitative indicator of the ϭϮϵ
toxicity of a compound based on the modelling of the entire dose-response relationship. BMDs ϭϯϬ
were derived by means of the following steps: i) selection of suitable dose-response datasets, ii) ϭϯϭ
choice of BMR, iii) fitting models using experimental data, and iv) selection of the best fitting ϭϯϮ
model. ϭϯϯ
For each compound, we based our BMD calculation on one selected study, describing the most ϭϯϰ
robust dose-response dataset. This kind of approach was also applied recently by Chepelev in ϭϯϱ
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order to derive BMDs for the protein expression involved in testicular toxicity (Chepelev et al., ϭϯϲ
2014). ϭϯϳ
ϭϯϴ
2.3. Selecting dose-response datasets ϭϯϵ
For each SVOC, available dose-response datasets were collected and selected on the basis of a ϭϰϬ
compromise between the amount of data available and comparability of the data between ϭϰϭ
compounds. The following criteria were used: i) availability of data for at least 3 dose levels and ϭϰϮ
1 control group; ii) same species (though not necessarily the same strain); iii) same window of ϭϰϯ
susceptibility (but not necessarily the same exposure duration); iv) same exposure route; v) ϭϰϰ
availability of raw data or means and standard errors of the means (SEM) or standard deviations ϭϰϱ
(SD) for each selected response. Where SDs were not provided in the publication and could not ϭϰϲ
be collected from the authors, a graphical estimation was made as described by the US EPA (US ϭϰϳ
EPA, 2005). If only SEMs were given, these were converted to SDs using the following equation: ϭϰϴ
ܵܦ ൌ ܵܧܯ ൈ ξ݊, where n is the sample size. ϭϰϵ
ϭϱϬ
2.4. Choice of BMR for a common effect ϭϱϭ
The response chosen should be linked to a reproductive effect and related to a maximum number ϭϱϮ
of SVOCs in order to consider a CRA. The Benchmark Response (BMR) is associated with the ϭϱϯ
BMD as a change in response relative to background (Crump, 1984). According to the data, this ϭϱϰ
response could be continuous (e.g., relative change from the control) or dichotomous (e.g., ϭϱϱ
presence or absence of an effect) (US EPA, 2012). In case of RPF derivation, the response should ϭϱϲ
either be linked to a specific mechanism of action or a consequence of a common mode of action ϭϱϳ
(a biological pathway leading to an adverse effect on the reproductive system). Because this ϭϱϴ
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response occurs at organism or cellular scale, it is a continuous response. Response rates in each ϭϱϵ
dataset were expressed as a proportion of the background response rate (i.e. background=1). ϭϲϬ
Where the adverse effect threshold is unknown, the BMRs used in this study will be default ϭϲϭ
values recommended by the US EPA (e.g., a decrease of 1 control SD for continuous datasets and ϭϲϮ
10% for dichotomous dataset) or a response level that would be qualified as adverse. ϭϲϯ
ϭϲϰ
2.5. Selection of the best fitting model ϭϲϱ
BMDs were computed using the PROAST software (www.rivm.nl/proast v32.2). The data was ϭϲϲ
continuous summary data (raw data was rarely available) and the Hill family of models was ϭϲϳ
selected for modelling the dose-response relationships, as follow in equations 1 to 4 (2 to 4 ϭϲϴ
parameters): ϭϲϵ
¹¸
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§
+
−=
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xay 1  ;ϭͿϭϳϬ
¸¸¹
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¨¨©
§
+
−= dd
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¹¸
·
©¨
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+
−
+=
xb
xcay 11  ;ϯͿϭϳϮ
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¸¸¹
·
¨¨©
§
+
−
+= dd
d
xb
xcay 11  ;ϰͿϭϳϯ
Where x is toxic compound concentration, a is the background response, b is the concentration of ϭϳϰ
the compound inducing 50% of the effect, d is the slope, and a*c is the response to an infinite ϭϳϱ
dose. The best fitting model from the Hill family was selected according to the procedure ϭϳϲ
described by Slob (Slob, 2002) with the likelihood ratio test. This tests whether increasing the ϭϳϳ
number of parameters in a model results in a statistically significant improvement to fit. ϭϳϴ
ϭϳϵ
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2.6. RPF estimation ϭϴϬ
RPFs were estimated using the previously-derived BMDs, according to the equation below: ϭϴϭ
ܴܲܨ௜ ൌ
ܤܯܦ௥௘௙
ܤܯܦ௜
Where RPFi is the RPF of the compound “i”; BMDi is the BMD of the compound “i”; BMDref is ϭϴϮ
the BMD of the reference compound. ϭϴϯ
RPFs express the potency of a compound “i” according to the reference compound. This ϭϴϰ
reference compound can be the most toxic compound within a group of compounds, or the most ϭϴϱ
documented for the selected effect.  ϭϴϲ
ϭϴϳ
3. Results ϭϴϴ
Fifty-eight SVOCs were selected based on the criteria described in the previous section, and are ϭϴϵ
presented in table 1. Of these, 23 were documented as having male reprotoxic properties ϭϵϬ
regardless of the mode or mechanism of action. A more precise description lead to the ϭϵϭ
identification of 3 groups having different modes of action and potentially acting via different ϭϵϮ
biological pathways. These pathways are summarized in figure 1 (adapted from Fournier et al. ϭϵϯ
2014a). ϭϵϰ
The group including the largest number of SVOCs - and for which the biological pathway is ϭϵϱ
known - is the group whose effect is described as decreasing the concentration of steroidogenesis ϭϵϲ
enzymes, resulting in a lower testosterone level; 18 SVOCs were concerned. ϭϵϳ
ϭϵϴ
3.1. Benchmark Doses Derivationϭϵϵ
3.1.1. Selection of Dose-Response DatasetsϮϬϬ
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Dose-response datasets meeting our selection criteria were available for just 6 of the 18 ϮϬϭ
compounds acting on steroidogenesis enzymes. The response measured in the toxicological ϮϬϮ
studies was the serum concentration of testosterone after oral-route exposure of adult male ϮϬϯ
rodents. ϮϬϰ
Lindane, dieldrin, alpha-endosulfan, chlorpyrifos-ethyl, deltamethrin, triclosan, 4-tert-ϮϬϱ
octylphenol and BDE-99 were excluded because there was no available dose-response ϮϬϲ
relationship for this effect (only one- and two- tested doses, respectively). Four other SVOCs ϮϬϳ
were excluded (permethrin, DBP, DiBP, DiNP) due to lack of comparable data (exposure of ϮϬϴ
rodents during different windows of susceptibility, i.e. pre- or post- natal).  ϮϬϵ
The central estimation (BMD) was used as the basis for calculation of RPFs rather than the ϮϭϬ
BMDL (Benchmark Dose Lower Bound = lower limit of a one-sided confidence interval on the Ϯϭϭ
BMD) which integrates uncertainty to experimental data, as suggested by the US EPA in 2010 ϮϭϮ
(US EPA, 2010). Ϯϭϯ
Table 2 briefly summarizes the selected study protocols and the decrease in serum testosterone Ϯϭϰ
relative to control results. In each case, dose-response data was obtained in adult rats orally Ϯϭϱ
exposed through sub-chronic to chronic exposure (15 to 150 days). There are 9 orders of Ϯϭϲ
magnitude between the highest dose tested (for DEHP) and the lowest one (for BPA). Ϯϭϳ
3.1.2. Choice of Response and BMR Ϯϭϴ
Serum testosterone concentration was measured in all studies. A decrease in this response was Ϯϭϵ
observed according to dose. It is reasonable to consider that this decrease may be linked to ϮϮϬ
adverse effects such as cryptorchidism, hypospadias or male fertility impairment, depending on ϮϮϭ
the window of susceptibility, as suggested by a group of experts of the United Nations ϮϮϮ
Environment Programme (UNEP) and WHO (WHO/UNEP, 2013). Two different BMRs were ϮϮϯ
chosen: a 10% and a 50% decrease in response compared to control serum testosterone. We ϮϮϰ
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consider a decrease of 50% of the serum testosterone to be significant (equivalent to the highest ϮϮϱ
documented standard deviation in our selected SVOCs). The use of a BMR equivalent to 1 ϮϮϲ
control standard deviation from the control mean is recommended by the US EPA (US EPA, ϮϮϳ
2012). The use of 10% as a BMR is intended to compare contaminants’ toxicity at lower doses, ϮϮϴ
though authors consider this effect size not meaningful. Eisenberg and colleagues observed a ϮϮϵ
10% difference in testosterone concentration between fertile and infertile men (Eisenberg et al., ϮϯϬ
2011). Furthermore, a 10% decrease in serum testosterone corresponds to the lowest documented Ϯϯϭ
standard deviation in our selected SVOCs. ϮϯϮ
Ϯϯϯ
3.1.3. BMD EstimationsϮϯϰ
The corresponding BMD10 and BMD50 are shown in table 3 (associated graphs are shown in Ϯϯϱ
supplementary data). Equation 2, with 3 estimated parameters and a null response at infinite Ϯϯϲ
doses, was selected for BPA. Equation 3, with 3 estimated parameters, slope equal to 1 and a Ϯϯϳ
non-null response at infinite doses, was selected for DEHP. Equation 1, with 2 free parameters, Ϯϯϴ
slope equal to 1 and a null response at infinite doses, was selected for the other four SVOCs. Ϯϯϵ
Since the response at infinite doses is equal to 0, BMD50 is the dose resulting in a 50% decrease ϮϰϬ
relative to the background response. Resulting RPFs for a 10% (RPF10) and 50% (RPF50) Ϯϰϭ
decrease are shown in table 4. The control values were included in the BMD calculations. ϮϰϮ
Ϯϰϯ
4. Discussion and Conclusion Ϯϰϰ
In this study, we derived BMDs for 6 SVOCs pertaining to different chemical families to which Ϯϰϱ
people are exposed in indoor environments, leading to RPF for BBP, BPA, B[a]P, DEP, DEHP Ϯϰϲ
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and cypermethrin. We have adapted the traditional risk assessment approach (NRC, 1983) by Ϯϰϳ
adding a grouping step, depending on SVOCs’ effects, as suggested in our previous work Ϯϰϴ
(Fournier et al, 2014b). This was done on the basis of their mode of action. In a second step, we Ϯϰϵ
calculated BMDs for the 6 SVOCs for which we were able to obtain sufficient information, ϮϱϬ
which in turn allowed RPFs to be derived. Ϯϱϭ
The RPFs calculation is based on the dose additivity assumption because it seems to best describe ϮϱϮ
the reality of mixture toxicity. In fact, the toxic equivalency and dose additivity models have Ϯϱϯ
already proved their potency in the mixture effects prediction. For example, Rider et al., in 2008, Ϯϱϰ
tested different hypotheses for predicting mixture reproductive effects in male offspring rats Ϯϱϱ
exposed during the period of sexual differentiation (Rider et al., 2008). They compared the Ϯϱϲ
observed responses from a mixture of 4 pesticides and 3 phthalates with predicted responses Ϯϱϳ
generated using a toxic equivalency approach and dose addition, response addition or integrated Ϯϱϴ
addition models. They validated the dose additivity assumption and showed that toxic Ϯϱϵ
equivalency and dose addition models provide the best fit to their observed responses even for ϮϲϬ
chemicals from different families which do not necessarily act via the same cellular mechanism Ϯϲϭ
of action. There were several reasons for basing our RPF calculation on a 10% and 50% decrease ϮϲϮ
in testosterone synthesis (BMD10 and BMD50), defined respectively as RPF10 and RPF50. First of Ϯϲϯ
all, as mentioned above, we do not know which level of inhibition of testosterone is harmful to Ϯϲϰ
human health. In this case, the US EPA recommends the use of an endpoint that is equivalent to a Ϯϲϱ
decrease of 1 control SD (US EPA, 2012). In our case, we have chosen to apply respectively the Ϯϲϲ
smallest and the largest of the documented control SDs (near 50% for BBP and 10% for BPA) for Ϯϲϳ
the choice of BMR. Ϯϲϴ
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We chose cypermethin as the index compound because its range of tested doses is intermediate Ϯϲϵ
among those tested for the other SVOCs. The difference in ranges of tested doses and toxicity ϮϳϬ
between contaminants yields a large range of RPF values (a factor of 109 between BPA and BBP Ϯϳϭ
for RPF10, a factor of 106 between B[a]P and BBP). The choice of the reference compound, ϮϳϮ
however, modifies neither the toxicity of each contaminant nor the order of their potency for the Ϯϳϯ
effect of interest. Ϯϳϰ
According to the RPF10, BPA shows the most toxic among the considered SVOCs (7,033,679 Ϯϳϱ
times more potent than cypermethrin for this effect) and BBP the least toxic (10.5 times less Ϯϳϲ
potent than cypermethrin). According to the RPF50, B(a)P seems to be the most toxic (1,630 Ϯϳϳ
times more potent than cypermethrin for this effect) and BBP the least one (10.5 times less potent Ϯϳϴ
than cypermethrin). Ϯϳϵ
For a 50% reduction in testosterone levels, we can observe that B(a)P is more toxic than BPA, ϮϴϬ
while this latter is most potent at 10% of the effect. According to our data, BPA is the most Ϯϴϭ
potent of of the study SVOCs at low doses. This is due to the difference between BPA and the ϮϴϮ
other SVOCs in terms of the slope of the curves (inclusion of the “d” parameter, see equation 2). Ϯϴϯ
Our data does not allow to derive a BMD50 (and RPF50) for DEHP because, according to the Hill Ϯϴϰ
equation used by PROAST, when the DEHP concentration is infinite, the response (decrease in Ϯϴϱ
serum testosterone concentration) only approaches 0.43 (=BMD43). The derivation of a BMD50Ϯϴϲ
for the DEHP could be performed with other data which investigated the same response, but Ϯϴϳ
specifically in pubertal rats (Noriega et al., 2009). According to this data, the BMD10 would be Ϯϴϴ
102.45 mg/kg bw/day and the BMD50 922.07 mg/kg bw/day. Ϯϴϵ
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We see here that the BMD10 based on adult data from Tonk et al. is 20 times lower than the ϮϵϬ
BMD10 based on pubertal rat from Noriega et al. This comparison shows that the toxic potency of Ϯϵϭ
DEHP compared to other compounds could be modified regarding to the window of exposure, ϮϵϮ
leading difficult the extrapolation of the “pubertal” BMD50 to an “adult” BMD50. Ϯϵϯ
In our case, three SVOCs (B[a]P, DEP and BBP) had parallel dose-response curves compared to Ϯϵϰ
the reference compound’s curve (cypermethrin) with a slope equal to 1 and a response at infinite Ϯϵϱ
concentrations equal to 0. On the other hand, for DEHP, at infinite concentrations, the response Ϯϵϲ
only approaches 0.43 rather than 0 and for BPA, the slope was different from 1. In these cases, Ϯϵϳ
the dose-response curves were not parallel compared to the reference. Thus, from a statistical Ϯϵϴ
point of view, the RPFs for B[a]P, DEP and BBP are more reliable than those for DEHP and Ϯϵϵ
BPA. ϯϬϬ
The main limitation of this work in a perspective of CRA for chemicals humans are exposed to, is ϯϬϭ
the lack of available and comparable data in the scientific literature. Among the 58 SVOCs that ϯϬϮ
were considered, others than the one we could include might be reprotoxic, but no study has been ϯϬϯ
published to date. Only 23 have been documented as having reprotoxic properties. Of these, 18 ϯϬϰ
are able to decrease testosterone synthesis. At the final step, the literature provided sufficient ϯϬϱ
comparable information for BMD calculation only for 6. ϯϬϲ
This limitation of the available information  was recently underlined by Wignall et al. in their ϯϬϳ
standardization of BMD calculations (Wignall et al., 2014). Another impediment is the lack of ϯϬϴ
comparability of the data in terms of the range of tested doses, windows of exposure, animal ϯϬϵ
strain, time of exposure, etc. The most striking example is the tested doses range, from 0.000005 ϯϭϬ
mg/kg bw/day for BPA, to 1000 mg/kg bw/day for DEHP, suggesting that BPA is the most ϯϭϭ
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potent toxic SVOC of our group for the study effect (abatement of serum testosterone ϯϭϮ
concentration); however, its action remains a subject of controversy in the literature. Our ϯϭϯ
requirements in term of data comparability (same species, same window of exposure, etc.) and ϯϭϰ
obviously the lack of data availability limit the datasets for our RPF computations. The more ϯϭϱ
precise and comparable we require our data to be, the less such data is available. ϯϭϲ
There is no data to compare with in the literature regarding RPFs derived from a variety of ϯϭϳ
chemical families. Among phthalates, RPFs were derived for DEHP and BBP acting on ϯϭϴ
testosterone synthesis (Benson, 2009; Hannas et al., 2011). In his CRA, Benson derived RPF for ϯϭϵ
6 phthalates including DEHP and BBP. For DEHP, the endpoint was smallness - or absence of - ϯϮϬ
male reproductive organs. For BBP (and the 4 other phthalates), the endpoint was decrease in ϯϮϭ
foetal testosterone production. The resulting RPFs were 1 and 0.21, based on the IC95 lower ϯϮϮ
bound of the BMD10 or the IC95 lower bound of the BMD corresponding to one standard ϯϮϯ
deviation for DEHP and BBP respectively. According to this method, DEHP appears to be 5 ϯϮϰ
times more potent than BBP, which is in line with our findings (10 times more potent according ϯϮϱ
to BMD10). This difference in potency might be explained by the use of different toxicity ϯϮϲ
indicators (BMDL versus BMD), the use of two different endpoints (small or absent male ϯϮϳ
reproductive organs for DEHP and a decrease in testosterone production for BBP), and a different ϯϮϴ
window of exposure (prenatal period for Benson, adult age for our work). ϯϮϵ
More recently, Hannas et al. have calculated RPFs for 5 phthalates. In contrast to Benson, they ϯϯϬ
undertook the in vivo tests on the same endpoint (decrease of foetal testosterone production) in ϯϯϭ
their own laboratory, making their data more comparable. They measured foetal testosterone ϯϯϮ
production and the expression of steroidogenesis enzymes after 5 days of in utero exposure for ϯϯϯ
each phthalate. The potency estimations were based on the derived effective doses 50 (ED50), ϯϯϰ
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corresponding to the dose responsible for 50% decrease of the foetal testosterone, equivalent to a ϯϯϱ
BMD50. In this case, DEHP appears to be one of the least potent phthalates for this effect, in ϯϯϲ
contrast to our data. This could be explained by the level of response associated with the chosen ϯϯϳ
indicators (10% versus 50%) or by the difference of window of exposure. In this case, only ϯϯϴ
DEHP is similar to the compounds included in our study so no potency comparison can be made. ϯϯϵ
While Benson concludes that DEHP is one of the most toxic phthalates within its chemical group ϯϰϬ
(2.5 and 4 times more potent than DiNP and DiBP respectively) using different endpoints, ϯϰϭ
Hannas finds that DEHP is approximately equipotent with DiBP and DiNP (RPFs of 0.06, 0.11 ϯϰϮ
and 0.15 for DiNP, DEHP and DiBP respectively) for the same endpoint. ϯϰϯ
For RPF calculations, it is very important to use comparable data and the same endpoint in order ϯϰϰ
to conduct a robust CRA. Also, future experiments should strive to standardise protocols (animals ϯϰϱ
tested, time of exposure, etc.) as well as the ranges and number of doses tested, which should be ϯϰϲ
as close as possible to human real exposures, allowing us to establish a dose-response curve. ϯϰϳ
Our approach takes into account actual population exposures, compounds from different ϯϰϴ
chemical families, and common effects and modes of action of SVOCs. For these reasons, we ϯϰϵ
think it is realistic and useful for future CRA studies. Research must continue in this direction to ϯϱϬ
improve the consideration of actual exposures in CRA. ϯϱϭ
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Figure 1: Adverse outcome pathway of 23 indoor semi volatile organic compounds (SVOCs) ϱϭϲ
on the reproductive, adapted from (Fournier et al., 2014b). ϱϭϳ
1(Gray et al., 2000); 2(Pan et al., 2006); 3(Borch et al., 2006); 4(Pereira et al., 2008); ϱϭϴ
5(Abdelouahab et al., 2011); 6(Alonso et al., 2010); 7(D’Cruz et al., 2012); 8(Chung et al., 2011); ϱϭϵ
9(Kuriyama and Chahoud, 2004); 10(Saradha et al., 2009); 11(Ronco et al., 2001); 12(Zhang et al., ϱϮϬ
2007); 13(Hu et al., 2011); 14(Singh and Pandey, 1990); 15(Schein and Thomas, 1975); 16(Fiorini ϱϮϭ
et al., 2004); 17(Farag et al., 2010); 18(Ismail and Mohamed, 2012); 19(Kumar et al., 2009); ϱϮϮ
20(Sainath et al., 2011); 21(Wilson et al., 2004); 22(Hannas et al., 2012); 23(Mograbi et al., 2003); ϱϮϯ
24(Posnack et al., 2015); 25(Liu et al., 2005); 26(Tonk et al., 2012); 27(Nagao et al., 2000); ϱϮϰ
28(Pereira et al., 2008); 29(Jiang et al., 2007); 30(Borch et al., 2004); 31(Shi et al., 2010); ϱϮϱ
32(Jayachandra and D’Souza, 2014)ϱϮϲ
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Table 1: Selected Semi Volatile Organic Compounds as candidates for grouping (detected 
in more than 10% of the French dwellings investigated) 
Chemical families Name 
Phthalates DEHP, DEP, DBP, BBP, DiBP, DiNP, DMP 
Polybromodiphenyl 
ethers (PBDEs) 
BDE-28, BDE-47, BDE-85, BDE-99, BDE-100, BDE-153, BDE-154, 
BDE-209 
Polychlorobiphenyls 
(PCBs) 
PCB-28, PCB-31, PCB-52, PCB-77, PCB-101, PCB-105, PCB-118, 
PCB-138, PCB-153, PCB-180 
Polycyclic aromatic 
hydrocarbons (HAPs) 
acenaphtene, anthracene, benzo(a)pyrene, fluorene, phenanthrene, 
fluoranthene, pyrene, benzo(a)anthracene, chrysene, 
benzo(k)fluoranthene,  benzo(b)fluoranthene, indeno(1,2,3-cd)pyrene, 
benzo(g,h,i)perylene, dibenzo(a,h)anthracene 
Pesticides 4’,4ǦDDE, 4’,4ǦDDT, dieldrine, alpha-endosulfan, lindane, 
chlorpyrifos-ethyl, diazinon, cyfluthrine, cypermethrine, deltamethrine, 
permethrine, oxadiazon, tributylphosphate 
Others 4-tert-butylphenol, 4-tert-octylphenol, bisphenol A, galaxolide, tonalide, 
triclosan 
 Based on (Mandin et al., 2014a) ; (Mandin et al., 2014b); (Blanchard et al., 2014) 
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Table 2: Available information in the literature on reproductive effects for the 6 Semi 
Volatile Organic Compounds retained for BenchMark Dose calculation 
SVOC Tested animals
Number 
of 
animals 
Time of 
exposure
Route of 
exposure
Tested 
doses 
(mg/kg 
bw/day)
Response 
(standard 
deviation)
(relative to 
control)
Reference
BBP Adult SD rats  25 105 days Oral 
0 
20 
100 
500 
1 (0.46) 
1.03 (0.54) 
0.77 (0.37) 
0.54 (0.31) 
Nagao et 
al., 2000 
BPA 
Adult 
Wistar 
rats  
6 45 days Oral 
0 
0.000005 
0.00005 
0.05 
0.5 
1 (0.1) 
0.84 (0.05) 
0.74 (0.05) 
0.62 (0.04) 
0.44 (0.06) 
D'Cruz et 
al., 2012 
B[a]P Adult SD rats  9 90 days Oral 
0 
0.001 
0.01 
0.1 
1 (0.31) 
1 (0.29) 
0.64 (0.17) 
0.25 (0.12) 
Chung et 
al., 2011 
DEP 
Adult 
Wistar 
rats  
6 150 days Oral 
0 
0.57 
1.425 
2.85 
1 (0.13) 
0.69 (0.11) 
0.63 (0.056) 
0.41 (0.025) 
Pereira et 
al., 2008 
DEHP 
Adult 
Wistar 
rats 
5 40 days Oral 
0 
1 
3 
10 
30 
100 
300 
1000 
1 (0.42) 
0.79 (0.17) 
0.70 (0.27) 
1.15 (0.50) 
0.52 (0.30) 
0.62 (0.32) 
0.47 (0.16) 
0.48 (0.18) 
Tonk et 
al., 2012 
Cyper-
methrin 
Adult 
SD rats  12 15 days Oral 
0 
6.25 
12.5 
25 
50 
1 (0.35) 
0.84 (0.35) 
0.79 (0.19) 
0.65 (0.33) 
0.49 (0.16) 
Hu et al., 
2011 
SVOCs: Semi Volatile Organic Compounds; SD: Sprague Dawley
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Table 3: Benchmark dose 10 and benchmark dose 50 for the 6 selected SVOCs 
SVOC Number of Hill 
parameters
BMD10 
(mg/kg bw/day)
BMD50 
(mg/kg bw/day)
B[a]P 2 0.0034 0.030 
BPA 3 7.72E-07 0.27 
DEP 2 0.24 2.18 
DEHP 3 5.04 / 
Cypermethrin 2 5.43 48.90 
BBP 2 57.34 520 
SVOCs: Semi Volatile Organic Compounds; BMD10: Benchmark Doses responsible of 10% of the selected effect 
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Table 4: Relative Potency Factor 10 and Relative Potency Factor 50 calculations from ϭ
BenchMark Doses for 6 Semi Volatile Organic Compounds detected in more than 10% of Ϯ
French dwellings and acting on testosterone synthesis in adult male rats ϯ
SVOC   RPF10 RPF50
B[a]P 1597 1630 
BPA 7033679 181 
DEP 22.63 22 
DEHP 1.08 / 
Cypermethrin 1 1 
BBP 0.095 0.095 
SVOCs: Semi Volatile Organic Compounds; RPF10: Relative Potency Factors for 10% of the selected effect ϰ
ϱ
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Highlights 
¾ Semi-volatile organic compounds (SVOCs) detected in more than 10% of French 
dwelling were selected 
¾ SVOCs were grouped according to their reprotoxic mode of action 
¾ Benchmark Doses and Relative Potency Factors based on a decrease in testosterone level 
in male rodent were derived 
¾ The main limitation is the lack of comparable toxicological data. 
